Harvard Bioscience Inc (NASDAQ:HBIO) appears in 64 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 929 | 0.15% | $0.00 |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 31 Dec, 2025 | 0 | 3,200,380 | 0.00% | $0.00 |
| Meros Investment Management, LP | 31 Dec, 2025 | 0 | 299,369 | 32.60% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -58,635 | -99.96% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 71,429 | 3.86% | $0.00 |
| Williams & Novak, LLC | 31 Dec, 2025 | 0 | 73,300 | 26.61% | $0.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | 702,937 | 65.71% | $0.00 |
| Pasadena Private Wealth, LLC | 31 Dec, 2025 | 0 | -198,911 | -81.55% | $0.00 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | 1,008,692 | 1,008.69% | $0.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 0 | 39,349 | 0.00% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | 152,763 | 17.59% | $0.00 |
| Callan Family Office, LLC | 31 Dec, 2025 | 0 | -53 | -0.18% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 538,260 | 113.52% | $0.00 |
| Abel Hall, LLC | 31 Dec, 2025 | 0 | -6,923 | -21.50% | $0.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 0 | 635,400 | 261.31% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 7,934 | 59.75% | $0.00 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 31 Dec, 2025 | 0 | 600,000 | 0.00% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -20,226 | -54.29% | $0.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 0 | -25,636 | -4.48% | $0.00 |
| Vanguard Personalized Indexing Management, LLC | 31 Dec, 2025 | 0 | 16,542 | 0.00% | $0.00 |